Multiple sclerosis: The proinflammatory cytokines lymphotoxin-α and tumour necrosis factor-α are upregulated in cerebrospinal fluid mononuclear cells

Journal of Neuroimmunology

Volumn 66, Issue 1-2, 1996, Pages 115-123

  Matusevicius, D ^a   Navikas, V ^a   Soderstrom M ^a   Xiao, B G ^a   Haglund, M ^a   Fredrikson, S ^a   Link, H ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

autoimmunity; cerebrospinal fluid; cytokines production; in situ hybridization; multiple sclerosis

Indexed keywords

LYMPHOTOXIN; MESSENGER RNA; MYELIN BASIC PROTEIN; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ADULT; ARTICLE; AUTOIMMUNITY; CEREBROSPINAL FLUID; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; IN SITU HYBRIDIZATION; MALE; MULTIPLE SCLEROSIS; PRIORITY JOURNAL;

EID: 0029943412     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/0165-5728(96)00032-X     Document Type: Article

References (39)

1. Baig, S., Olsson, T., Yu-Ping, J., Höjeberg, B., Cruz, M. and Link, H. (1991) Multiple sclerosis: Cells secreting antibodies against myelin-associated glycoprotein are present in cerebrospinal fluid. Scand. J. Immunol. 33, 73-79.
2. Brosnan, C.F., Selmaj, K. and Raine, C.S. (1988) Hypothesis: A role for tumor necrosis factor in immune mediated demyelination and its relevance to multiple sclerosis. J. Neuroimmunol. 18, 87-94.
3. Cannella, B. and Raine, C.S. (1989) Cytokines up-regulate Ia expression in organotypic cultures of CNS tissue. J. Neuroimmunol. 24, 239-248.
4. Cavender, D.E., Edelbaum, D. and Ziff, M. (1989) Endothelial cell activation induced by tumor necrosis factor and lymphotoxin. Am. J. Pathol. 134, 551-560.
5. Dagerlind, Å., Friberg, K., Bean, A.J. and Hökfelt, T. (1992) Sensitive mRNA detection using unfixed tissue: combined radioactive and non-radioactive in situ hybridization histochemistry. Histochemistry 98, 39-49.
6. Deibler, G.E., Martensson, R.E. and Kies, M.V. (1972) Large scale preparation of myelin basic protein from central nervous tissue of several animal species. Prep. Biochem. 2, 139-165.
7. Ferraiolo, B.L., Moore, J.A., Crase, D., Gribling, P., Wilking, H. and Baughman, R. (1988) Pharmacokinetics and tissue distribution of recombinant human tumor necrosis factor-α in mice. Drug Metab. Dispos. 16, 270-275.
8. Franciota, D.M., Grimaldi, L.M.E., Martino, G.V., Piccolo, G., Bergamaschi, R., Citterio, A. and Melzi d'Eril, G.V. (1989) Tumor necrosis factor in serum and cerebrospinal fluid of patients with multiple sclerosis. Ann. Neurol. 26, 787-789.
9. Gallo, P., Piccinno, M.G., Krzalic, L. and Tavolato, B. (1989) Tumor necrosis factor alpha (TNF-α) and neurological diseases. Failure in detecting TNF-α in the cerebrospinal fluid from patients with multiple sclerosis, AIDS dementia complex and brain tumors. J. Neuroimmunol. 23, 41-44.
10. Gray, P.W., Aggarwal, B., Benton, C.V., Bringman, T.S., Henzel, W.J., Jarrell, J.A., Leung, D.W., Moffat, B., Ng, P., Svedersky, L.P., Palladino, M.A. and Nedwin, G.E. (1984) Cloning and expression of cDNA for human lymphotoxin, a lymphokine with tumor necrosis activity. Nature 312, 721-724.
11. Hampson, D.R. and Poduslo, S.E. (1986) Purification of proteolipid protein and production of specific antiserum. J. Immunol. 11, 117-129.
12. Hauser, S.L., Bhan, A.K., Gilles, F., Kemp, M., Kerr, C. and Weiner, H.L. (1986) Immunohistochemical analysis of the cellular infiltrate in multiple sclerosis lesions. Ann. Neurol. 19, 578-587.
13. Hauser, S.L., Doolittle, T.H., Lincoln, R., Brown, R.H. and Dinarello, C.A. (1990) Cytokine accumulations in CSF of multiple sclerosis patients: frequent detection of IL-1 and tumor necrosis factor but not interleukin-6. Neurology 40, 1735-1739.
14. Kurtzke, J.F. (1983) Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 33, 1444-1452.
15. Link, H. (1991) The cerebrospinal fluid in multiple sclerosis. In: M. Swash and J. Oxbury (Eds.), Textbook of Neurology, Churchil Livingstone, Edinburgh, pp. 1128-1139.
16. Link, J. (1994a) Interferon-γ, interleukin-4 amd transforming growth factor-β mRNA expression in multiple sclerosis and myasthenia gravis. Acta Neurol. Scand. 90, Suppl. 1-58.
17. Link, J., Söderström, M., Ljungdahl, Å., Höjeberg, B., Olsson, T., Xu, Z., Fredrikson, S., Wang, Z.Y. and Link, H. (1994b) Organ specific autoantigens induce interferrn-γ and interleukin-4 mRNA expression in mononuclear cells in multiple sclerosis and myasthenia gravis. Neurology 44, 728-734.
18. Link, J., Söderström, M., Olsson, T., Höjeberg, B., Ljungdahl, Å and Link, H. (1994c) Increased TGF-β, IL-4 and IFN-γ in multiple sclerosis. Ann. Neurol. 36, 379-386.
19. Maimone, D., Gregory, S., Arnason, B.G.W. and Reder, A.T. (1991) Cytokine levels in the cerebrospinal fluid and serum of patients with multiple sclerosis. J. Neuroimmunol. 32, 67-74.
20. Navikas, V., He, B., Link, J., Hillert, J., Haglund, M., Söderström, M., Fredrikson, S., Höjeberg, B., Olsson, T. and Link, H. (1996) Augmented expression of tumor necrosis factor-α and lymphotoxin mRNA in mononuclear cells in multiple sclerosis and optic neuritis. Brain 119, 213-223.
21. Olsson, T., Kostulas, V. and Link, H. (1984) Improved detection of oligoclonal IgG in cerebrospinal fluid by isoelectric focusing in agaros, double antibody peroxidase labelling, and avidin-biotin amplification. Clin. Chem. 30, 1246-1249.
22. Olsson, T., Wang, W.Z., Höjeberg, B., Kostulas, V., Jiang, Y.P., Andersson, G., Ekre, H.P. and Link, H. (1990) Autoreactive T lymphocytes in multiple sclerosis determined by antigen induced secretion of interferon-gamma. J. Clin. Invest. 86, 981-985.
23. Pennica, D., Nedwin, G.E., Hayflick, J.S., Seeburg, P.H., Derynck, R., Palladino, M.A., Kohr, W.J., Aggarwal, B.B. and Goedel, D.V. (1984) Human tumor necrosis factor: precursor structure, expression and homology to lymphotoxin. Nature 312, 452-457.
24. Peter, J.B., Boctor, F.N. and Tourtellotte, W.W. (1991) Serum and CSF levels of IL-2, sIL-2R, TNF-α and IL-1β in chronic progressive multiple sclerosis: expected lack of clinical utility. Neurology 41, 121-123.
25. Poser, C.M., Paty, D.W., Scheinberg, McDonald, W.I., Davis, F.A., Ebers, G.C., Johnson, K.P., Sibley, W.A., Silberberg, D.H. and Tourtellotte, W.W. (1993) New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann. Neurol. 13, 227-231.
26. Raine, C. (1994) The Dale E. McFarlin memorial lecture: The immunology of the multiple sclerosis. Ann. Neurol. 36, S61-72.
27. Rieckmann, P., Albrecht, M., Kitze, B., Weber, T., Tumani, H., Broocks, A., Luer, W. and Poser, S. (1994) Cytokine mRNA levels in mononuclear blood cells from patients with multiple sclerosis. Neurology 44, 1523-1526.
28. Rieckmann, P., Albrecht, M., Kitze, B., Weber, T., Tumani, H., Broocks, A., Luer, W., Helwig, A. and Poser, S. (1995) Tumor necrosis factor-α messenger RNA expression in patients with relapsing-remitting multiple sclerosis associated with disease activity. Ann. Neurol. 37, 82-88.
29. Robbins, D.S., Shirazi, Y., Drysdale, B-E., Lieberman, A., Shin, H.S. and Shin, M.L. (1987) Production of cytotoxic factor for oligodendrocytes by stimulated astrocytes. J. Immunol. 139, 2593-2597.
30. Ruddle, N.H. (1994) Tumor necrosis factor-beta/Lymphotoxin-alpha. In: A. Thompson (Ed.), The Cytokine Handbook, 2nd edit., Academic Press, London, pp. 305-318.
31. Selmaj, K. and Raine, C.S. (1988) Tumor necrosis factor mediates myelin and oligodendrocyte damage in vitro. Ann. Neurol. 21, 339-346.
32. Selmaj, K., Raine, C.S., Cannella, B. and Brosnan, C.F. (1991a) Identification of lymphotoxin and tumor necrosis factor in multiple sclerosis lesions. J. Clin. Invest. 87, 949-954.
33. Selmaj, K., Raine, C.S., Farooq, M., Norton, W.T. and Brosnan, C.F. (1991b) Cytokine cytotoxicity against oligodendrocytes: Apoptosis induced by lymphotoxin. J. Immunol. 147, 1522-1529.
34. Sharief, M.K. and Hentges, R. (1991) Association between tumor necrosis factor-α and disease progression in patients with multiple sclerosis. N. Engl. J. Med. 325, 467-472.
35. Sun, J.B., Olsson, T., Wang, W.X., Xiao, B-G., Kostulas, V., Fredrikson, S., Ekre, H.P. and Link, H. (1991a) Autoreactive T and B cells responding to myelin proteolipid protein in multiple sclerosis and controls. Eur. J. Immnol. 21, 1461-1468.
36. Sun, J.B., Link, H., Xiao, B-G., Diener, P., Andersson, G., Ekre, H.P., Linington, C. and Olsson, T. (1991b) T and B cell responses to myelin-oligodendrocyte glycoprotein in multiple sclerosis. J. Immunol. 146, 1490-1495.
37. Tibbling, G., Link, H. and Öhman, S. (1977) Principles of albumin and IgG analyses in neurological disorders. I. Establishment of reference values. Scan. J. Clin. Lab. Invest. 37, 385-390.
38. Tsukada, N., Miagi, K., Matsuda, M., Yanagisawa, N. and Yone, K. (1991) Tumor necrosis factor and interleukin-1 in CSF and sera of patients with multiple sclerosis. Ann. Neurol. 104, 230-234.
39. Wingren, A.G., Dahlenborg, K., Bjorklund, M., Hedlund, G., Kalland, T., Sjogren, H.O., Ljungdahl, A., Olsson, T., Ekre, H.P., Sansom, D. et al. (1993) Monocyte regulated IFN-γ production in human T cells involves CD2 signaling. J. Immunol. 151, 1328-1336.